FDA Inspection 1177870 — IBSA Farmaceutici Italia Srl
The FDA completed an inspection of IBSA Farmaceutici Italia Srl on Jul 14, 2022 in Lodi. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 14, 2022
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Lodi (Italy)